60 Day FRN

47171

Federal Register / Vol. 83, No. 181 / Tuesday, September 18, 2018 / Notices
• Ads for the survivorship survey will
be targeted toward users who ‘like’,
search, and/or visit web pages geared
toward survivors, such as the National
Cancer Survivors Day Facebook page.
Individuals will be screened for
eligibility until the target of up to 1,000
completes is met. It is expected that to
reach 1,000 eligible respondents for the
survivorship survey, 3,000 individuals
will need to be screened.

• Ads for the high-risk survey will be
targeted toward users who ‘like’, visit,
or search for terms related to cancer and
genetic testing. Individuals will be
screened for eligibility until the target of
up to 1,000 completes is met. It is
expected that to reach 1,000 eligible
respondents for the high-risk survey,
2,000 individuals will need to be
screened.
• Eligible high-risk participants will
be invited via email to participate in the

follow-up high-risk survey. Additional
social media ads may also be placed,
using the targeting methods described
above. In order to survey 1,000 high-risk
adults, it is expected that an additional
4,000 individuals will be screened.
Participation in this project is
completely voluntary and there are no
costs to the respondents other than their
time.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average
burden per
response
(in hours)

Total
burden
(in hours)

Form name

Adults over 40 ...................................
Cancer Survivors ..............................
Adults at High Risk for Cancer .........
Adults at High Risk for Cancer .........
Adults over 40 ...................................
Cancer Survivors ..............................
Adults at High Risk for Cancer .........
Adults at High Risk for Cancer .........

Survey Screener ..............................
Survey Screener ..............................
Survey Screener ..............................
Follow-Up Screener .........................
General Population Survey ..............
Survivorship Survey .........................
High-Risk Survey .............................
High-Risk Follow-Up Survey ............

1,500
3,000
2,000
4,000
1,000
1,000
1,000
1,000

1
1
1
1
1
1
1
1

2/60
2/60
2/60
2/60
22/60
15/60
19/60
17/60

50
100
67
133
367
250
317
283

Total ...........................................

...........................................................

........................

........................

........................

1,567

Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–20247 Filed 9–17–18; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.

VerDate Sep<11>2014

19:14 Sep 17, 2018

Jkt 244001

Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
DP19–002, Packaging and Spreading
Proven Pediatric Weight Management
Interventions for Use by Low-Income
Families.
Dates: December 11–12, 2018.
Times: 10:00 a.m.–6:00 p.m., EST.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
Jaya
Raman Ph.D., Scientific Review Officer,
CDC, 4770 Buford Highway, Mailstop,
F80, Atlanta, Georgia 30341, Telephone:
(770) 488–6511, [email protected].
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.

FOR FURTHER INFORMATION CONTACT:

Notice of Closed Meeting

daltland on DSKBBV9HB2PROD with NOTICES

Number of
respondents

Type of respondent

Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–20289 Filed 9–17–18; 8:45 am]
BILLING CODE 4163–18–P

PO 00000

Frm 00048

Fmt 4703

Sfmt 4703

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–18–1061; Docket No. CDC–2018–
0087]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).

AGENCY:

ACTION:

Notice with comment period.

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Behavioral Risk Factor
Surveillance System (BRFSS), an annual
state-based health survey that produces
state-level information on health risk
behaviors, health conditions, and
preventive health practices that are
associated with chronic diseases,
infectious diseases, and injury.

SUMMARY:

E:\FR\FM\18SEN1.SGM

18SEN1

47172

Federal Register / Vol. 83, No. 181 / Tuesday, September 18, 2018 / Notices

CDC must receive written
comments on or before November 19,
2018.

DATES:

You may submit comments,
identified by Docket No. CDC–2018–
0087 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
daltland on DSKBBV9HB2PROD with NOTICES

ADDRESSES:

VerDate Sep<11>2014

19:14 Sep 17, 2018

Jkt 244001

whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Behavioral Risk Factor Surveillance
System (BRFSS)—Revision—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC is requesting OMB approval to
revise information collection for the
Behavioral Risk Factor Surveillance
System (BRFSS) for the period of 2019–
2022. The BRFSS is a nationwide
system of cross-sectional telephone
health surveys administered by health
departments in states, territories, and
the District of Columbia (collectively
referred to here as states) in
collaboration with CDC. The BRFSS
produces state-level information
primarily on health risk behaviors,
health conditions, and preventive health
practices that are associated with
chronic diseases, infectious diseases,
and injury. Designed to meet the data
needs of individual states and
territories, the CDC sponsors the BRFSS
information collection project under a
cooperative agreement with states and
territories. Under this partnership,
BRFSS state coordinators determine
questionnaire content with technical
and methodological assistance provided
by CDC. For most states and territories,
the BRFSS provides the only sources of
data amenable to state and local level
health and health risk indicator uses.
Over time, it has also developed into an
important data collection system that

PO 00000

Frm 00049

Fmt 4703

Sfmt 4703

federal agencies rely on for state and
local health information and to track
national health objectives such as
Healthy People.
CDC bases the BRFSS questionnaire
on modular design principles to
accommodate a variety of state-specific
needs within a common framework. All
participating states are required to
administer a standardized core
questionnaire, which provides a set of
shared health indicators for all BRFSS
partners. The BRFSS core questionnaire
consists of fixed core, rotating core, and
emerging core questions. Fixed core
questions are asked every year. Rotating
core questions cycle on and off the core
questionnaire during even or odd years,
depending on the question. Emerging
core questions are included in the core
questionnaire as needed to collect data
on urgent or emerging health topics
such as influenza. In addition, the
BRFSS includes a series of optional
modules on a variety of topics. In off
years, when the rotating questions are
not included in the core questionnaire,
they are offered to states as optional
modules. This framework allows each
state to produce a customized BRFSS
survey by appending selected optional
modules to the core survey. States may
select which, if any, optional modules
to administer. As needed, CDC provides
technical and methodological assistance
to state BRFSS coordinators in the
construction of their state-specific
surveys. Each state administers its
BRFSS questionnaire throughout the
calendar year.
CDC periodically updates the BRFSS
core survey and optional modules. The
purpose of this Revision request is to
add the following topics to the
questionnaires: Myalgic
encephalomyelitis/chronic fatigue
syndrome; hepatitis treatment; adverse
childhood experiences; food stamps;
and opioid use and misuse. In addition,
this request seeks approval for
reinstating topics which have been
included in BRFSS in the past,
dependent upon state interest and
funding.
Participation is voluntary and there is
no cost to participate. The average time
burden per response will be 22 minutes.
The total annual time burden across all
respondents will be approximately
241,519 hours.

E:\FR\FM\18SEN1.SGM

18SEN1

47173

Federal Register / Vol. 83, No. 181 / Tuesday, September 18, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents

Form name

U.S. General Population .................................

Landline Screener ..........................................
Cell Phone Screener ......................................
Field Test Screener ........................................
BRFSS Core Survey ......................................
BRFSS Optional Modules ..............................
Field Test Survey ...........................................

Annual Survey Respondents (Adults >18
Years).
Field Test Respondents (Adults >18 Years) ..

Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–20248 Filed 9–17–18; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–0840]

daltland on DSKBBV9HB2PROD with NOTICES

Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Formative
Research and Tool Development’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on April 23, 2018 to obtain
comments from the public and affected
agencies. CDC received one comment
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;

VerDate Sep<11>2014

19:14 Sep 17, 2018

Jkt 244001

Number of
respondents

(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to [email protected]. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Formative Research and Tool
Development (OMB Control No. 0920–
0840, Expiration 1/31/2019)—
Extension—National Center for HIV/
AIDS, Viral Hepatitis, STD, TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention, National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP) requests
approval for an extension and a three
year approval for the previously
approved Generic Clearance,
‘‘Formative Research and Tool
Development’’. This information
collection request is designed to allow
NCHHSTP to conduct formative
research information collection
activities used to inform many aspects
of surveillance, communications, health
promotion, and research project
development for NCHHSTP’s four
priority diseases (HIV/AIDS, sexually

PO 00000

Frm 00050

Fmt 4703

Sfmt 4703

375,000
292,682
900
480,000
440,000
500

Number of
responses per
respondent
1
1
1
1
1
1

Average
burden per
response
(in hours)
1/60
1/60
1/60
15/60
15/60
45/60

transmitted diseases/infections (STD/
STI), viral hepatitis, tuberculosis
elimination and the Division of School
and Adolescent Heath (DASH).
Formative research is the basis for
developing effective strategies including
communication channels, for
influencing behavior change. It helps
researchers identify and understand the
characteristics/interests, behaviors and
needs of target populations that
influence their decisions and actions.
Formative research is integral in
developing programs, as well as
improving existing and ongoing
programs. Formative research also looks
at the community in which a public
health intervention is being or will be
implemented, and helps the project staff
understand the interests, attributes and
needs of different populations and
persons in that community. Formative
research is research that occurs before a
program is designed and implemented,
or while a program is being conducted.
NCHHSTP formative research is
necessary for developing new programs
or adapting programs that deal with the
complexity of behaviors, social context,
cultural identities, and health care that
underlie the epidemiology of HIV/AIDS,
viral hepatitis, STDs, and TB in the U.S,
as well as for school and adolescent
health. CDC conducts formative
research to develop public-sensitive
communication messages and user
friendly tools prior to developing or
recommending interventions, or care.
Sometimes these studies are entirely
behavioral but most often they are
cycles of interviews and focus groups
designed to inform the development of
a product.
Products from these formative
research studies will be used for
prevention of HIV/AIDS, Sexually
Transmitted Infections (STI), viral
Hepatitis, and Tuberculosis. Findings
from these studies may also be
presented as evidence to diseasespecific National Advisory Committees,
to support revisions to recommended
prevention and intervention methods, as
well as new recommendations.

E:\FR\FM\18SEN1.SGM

18SEN1